Home Orexigen's Contrave Sales Recover - Investors Should Look To Europe
 

Keywords :   


Orexigen's Contrave Sales Recover - Investors Should Look To Europe

2015-02-19 12:27:30| Biotech - Topix.net

Contrave, the anti-obesity pill from Orexigen saw sales increase by 10% this past week. Contrave sold just above 8,400 scripts for its best week to date.

Tags: to sales europe investors

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Mortgage rates hitting affordability - Nationwide
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Public Advisory Number 10A
01.07Summary for Hurricane Beryl (AT2/AL022024)
01.07Tropical Storm Chris Graphics
01.07Tropical Storm Chris Public Advisory Number 2A
01.07Atlantic Tropical Weather Outlook
01.07Eastern North Pacific Tropical Weather Outlook
More »